June 1, 2016 / 9:27 PM / a year ago

BRIEF-TSO3 responds to U.S. FDA on extended claims, gives operations update

June 2 (Reuters) - Tso3 Inc

* TSO3 responds to u.s. Regulators on extended claims and provides operations update

* Responded to a previously announced request for additional information by U.S. Food and Drug Administration

* Co's response allows FDA to continue their review for market clearance on extended claims for sterizone VP4 sterilizer in U.S.

* Production and operational improvements co made on assembly facility had a minimal impact on Q2 2016 production

* Substantially completed its improvements to its manufacturing facility in Québec

* Operational improvements to its assembly facility are designed to increase assembly capacity and efficiency Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below